What is the appropriate next work‑up and management for a patient with normal ESR and CRP, normal head CT and MRI after a transient stroke‑like episode, who is taking amlodipine (5 mg) for hypertension and NSAIDs plus opioids for back pain?

Appropriate Next Work-Up and Management

Your patient requires urgent vascular imaging of the neck and cardiac evaluation to identify the stroke mechanism, followed by optimization of secondary stroke prevention therapy including addition of an ACE inhibitor/diuretic combination and antiplatelet therapy.

Immediate Next Steps: Complete the Stroke Work-Up

Your patient had stroke-like symptoms with normal brain imaging (CT and MRI), which means you've ruled out acute hemorrhage and large vessel infarction—but you haven't completed the essential evaluation to prevent a future stroke. The normal ESR (2) and CRP (3.3) effectively rule out inflammatory/vasculitic causes.

Required Vascular Imaging

You must obtain cervical and intracranial vascular imaging immediately 1. The guidelines are explicit that for patients presenting with transient stroke-like symptoms (TIA), vascular imaging is critical for:

• Identifying carotid stenosis requiring revascularization
• Detecting intracranial large vessel disease
• Determining stroke mechanism for targeted secondary prevention

Options include:

• CTA of head and neck (fastest, widely available)
• MRA of head and neck (if MRI already performed)
• Carotid duplex ultrasound (for extracranial vessels)

Required Cardiac Evaluation

Obtain an ECG immediately and consider prolonged cardiac monitoring 2:

• ECG to detect atrial fibrillation or other arrhythmias
• If initial ECG is normal but cardioembolic mechanism suspected, prolonged monitoring up to 30 days is recommended to detect paroxysmal atrial fibrillation 2
• Echocardiography if cardiac source suspected (particularly given your patient's age and presentation)

Blood Pressure Management

Current Regimen Assessment

Your patient is on amlodipine 5 mg monotherapy. This is inadequate for secondary stroke prevention 3, 4, 3.

Recommended Changes

Switch to or add an ACE inhibitor/diuretic combination 3. The Canadian and ACC/AHA guidelines specifically state:

• ACE inhibitor/diuretic combination is preferred (Grade B) for secondary stroke prevention 3
• Target BP <140/90 mmHg (or <130/80 mmHg per newer ACC/AHA guidelines) 4

Practical approach:

• Add an ACE inhibitor (e.g., perindopril 4 mg) + thiazide diuretic (e.g., indapamide 2.5 mg) to the current amlodipine
• Alternatively, switch entirely to ACE inhibitor/diuretic combination if BP control allows
• Do NOT combine ACE inhibitor with ARB in stroke patients—this is explicitly contraindicated (Grade B) 3

Timing of Initiation

Start antihypertensive optimization after the first 24-48 hours from symptom onset 5, 4. Since your patient already presented to the ER and is now stable, you can initiate therapy now.

Antiplatelet Therapy

Initiate antiplatelet therapy immediately 4, 6:

• Aspirin 325 mg daily is the baseline recommendation
• If high-risk TIA (which stroke-like symptoms suggest), consider dual antiplatelet therapy (aspirin + clopidogrel 75 mg) for 21-90 days, then transition to single agent 6
• The specific duration and choice depends on vascular imaging findings (e.g., if intracranial stenosis found, dual therapy for up to 90 days is reasonable) 6

Critical Medication Safety Issue: NSAIDs

Your patient is taking NSAIDs for back pain—this is problematic:

• NSAIDs increase cardiovascular and cerebrovascular risk 7
• NSAIDs can interfere with antiplatelet therapy
• Strongly consider alternative pain management:
  • Acetaminophen (though monitor cardiovascular effects)
  • Physical therapy
  • Topical agents
  • If opioids already prescribed, optimize that regimen rather than adding NSAID risk

The combination of NSAIDs with recent stroke-like symptoms and need for antiplatelet therapy creates unnecessary bleeding and cardiovascular risk.

Lipid Management

Check fasting lipid panel and initiate high-intensity statin therapy 4, 6:

• High-intensity statin (e.g., atorvastatin 40-80 mg or rosuvastatin 20-40 mg) is recommended for secondary stroke prevention
• Target LDL <70 mg/dL (or even <55 mg/dL per some guidelines)

Additional Metabolic Screening

• Hemoglobin A1c to screen for diabetes
• Fasting glucose
• Complete metabolic panel (renal function before starting ACE inhibitor)

Follow-Up Timeline

1. Urgent (within 24-48 hours): Vascular imaging, ECG, labs
2. Within 1 week: Cardiology evaluation if indicated, neurology follow-up
3. Within 2-4 weeks: Reassess BP control, medication tolerance, ensure adherence

Common Pitfalls to Avoid

• Don't assume normal brain imaging means no stroke risk—TIA patients have 5-15% annual recurrence risk 3
• Don't continue amlodipine monotherapy—ACE inhibitor/diuretic combination is evidence-based for neuroprotection 3
• Don't delay vascular imaging—carotid stenosis >50% requires specific management 1
• Don't continue NSAIDs—find alternative pain management
• Don't forget cardiac evaluation—atrial fibrillation changes entire management strategy